Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority GroupsGlobeNewsWire • 04/29/21
Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second DosesGlobeNewsWire • 04/27/21
PerkinElmer Supports PROXIDRUGS Consortium Aimed at Advancing Targeted Protein Degradation/PROTAC DrugsBusiness Wire • 04/22/21
PerkinElmer to Present at BofA Securities 2021 Virtual Health Care ConferenceBusiness Wire • 04/21/21
PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021Business Wire • 04/13/21
Horizon Discovery Extends Gene Modulation Portfolio with Industry First Synthetic Single Guide RNA and Patent Pending dCas9 Repressor for CRISPR InterferenceBusiness Wire • 03/29/21
PerkinElmer Further Expands Industry-Leading Signals™ Informatics Capabilities in Biologics Drug DiscoveryBusiness Wire • 03/17/21
PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 MutationsBusiness Wire • 03/09/21
PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass ScreeningBusiness Wire • 02/23/21